COVID-19 advice hub

COVID-19 advice hub

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of 11 March 2020, the rapid circulation of SARS-CoV-2 has been classified as a pandemic by the World Health Organization.

This page is collates relevant guidance from NHS England, Public Health England, the UK Government, and professional bodies across the UK and beyond to support services with both the design and delivery of their pandemic response.

Jump to the following areas based on your needs:



Service organisation and resourcing

    1. freeing up maximum possible inpatient and critical care capacity
    2. preparing, and responding to, large numbers of inpatients requiring respiratory support
    3. supporting staff, and maximising staff availability
    4. supporting newly announced wider population measures
    5. stress-testing operational readiness
    6. removing routine burdens
    1. Phase 1: COVID-19 case identification and immediate response
    2. Phase 2: COVID-19 coordination services
    3. Minimum pathway accessories required, including for diagnostics, case transport, and infection prevention and control
    4. Managing illness during self-isolation based on symptom severity (‘disposition’).

NHS England

Royal College of Anaesthetists, Association of Anaesthetists, Faculty of Intensive Care Medicine, Intensive Care Society, and UK Clinical Pharmacy Association

Clinical management of acute COVID-19-related illness

Acute care

COVID-19 rapid NICE guidelines:

Rapid evidence summaries:

National Institute for Health and Care Excellence

Faculty of Intensive Care Medicine

Resuscitation Council UK

Specific patient groups and conditions

Adrenal/pituitary insufficiency



Chronic myeloid leukaemia

Cardiovascular disease

Chronic obstructive pulmonary disease


Congenital heart disease


Fragility fractures







Receiving angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) therapy

The current international consensus is that there is no good evidence that stopping ACEis or ARBs will prevent or alleviate COVID-19.

Immune thrombocytopenic purpura

Inflammatory bowel disease (including Crohn’s disease and ulcerative colitis)

Interstitial lung disease

Lung cancer and mesothelioma

Multiple sclerosis

Obstructive sleep apnoea





Rheumatological conditions

Sickle cell disease and thalassaemia





Trauma and orthopaedics

Patients taking warfarin

Equipment standards


Other areas

Advising the public

Specialised Medicine  COVID-19 news

PHE publishes position statement on evaluations of selected diagnostic tests for COVID-19

ESC issues guidance on managing cardiovascular disease during the COVID-19 pandemic

Genomes of COVID-19 survivors to be sequenced to understand predisposition to severe disease

Radiologists warn that ‘capacity will be much, much less than demand’ after COVID-19

NICE publishes two further rapid guidelines on COVID-19

Professional bodies issue guidance on women’s health during the COVID-19 pandemic

Clinical trial evaluates bemcentinib for the treatment of COVID-19

MHRA launches coronavirus yellow card reporting site

RCPCH publishes guidance on COVID-19-related paediatric multisystem inflammatory syndrome

BASP releases guidance on adapting stroke services during the COVID-19 pandemic

NICE publishes COVID-19 rapid guidance on acute kidney injury in hospital

BHIVA releases guidance on the management of HIV in adults during the COVID-19 pandemic

EMA updates guidance on the management of clinical trials during the COVID-19 outbreak

New NICE rapid guidelines published

COVID-19 guidelines on dermatological conditions, bone disorders, and end of life care updated

Second phase of the NHS response to COVID-19 revealed

Results from trials of remdesivir for COVID-19 published

US COVID-19 vaccine trial to begin next week

Landmark agreement for COVID-19 vaccine announced

COVID-19 associated with large-vessel stroke in patients younger than 50 years

NICE updates COVID-19 rapid guidance on critical care in adults

COVID-19 rapid guidance on rheumatological autoimmune, inflammatory, and metabolic bone disorders updated by NICE

MHRA reports severe disruption to the supply of kits for renal replacement therapy in critical care

Public Health England updates guidance on COVID-19 with information on care homes

NICE updates rapid guidance on managing COVID-19 symptoms in the community, including at the end of life

European regulatory framework guidance published in light of challenges posed by COVID-19

NICE publishes rapid evidence summary on NSAIDs and COVID-19

New rapid guidelines on cystic fibrosis, chronic obstructive pulmonary disease, and dermatological conditions

General Medical Council issues statement on regulation during the COVID-19 outbreak

The King’s Fund publishes briefing on critical care services

DHSC launches coronavirus status checker app for people to share their symptoms

Clinical trial data on the safety and efficacy of remdesivir for COVID-19 anticipated

Chief Medical Officer requests enrolment of patients with COVID-19 in clinical trials

Saving Babies’ Lives care bundle revised to include information on COVID

New measures agreed to ensure the availability of medicines during the COVID-19 outbreak

NICE publishes further rapid guidelines on COVID-19

Specialty guides for patient management during the COVID-19 pandemic published

NHS England postpones activity on the Commercial Framework

UK commits to contributing £210 million to the global search for a COVID-19 vaccine

New technologies introduced to aid in the fight against COVID-19

NICE switches its focus to diagnostic or therapeutic interventions for COVID-19

Human monoclonal antibody candidates against SARS-CoV-2 identified

Clinical trials of a candidate vaccine for COVID-19 to begin by September 2020

NICE publishes new rapid guideline on COVID-19 and radiotherapy

Guidance issued on switching patients from warfarin to direct oral anticoagulants in light of COVID-19

WHO warns against use of untested drugs to treat COVID-19

NHS England to take on key CCG powers until 31 December 2020

MHRA issues new guidance around COVID-19

NICE publishes first three rapid guidelines on COVID-19

NICE to offer free Scientific Advice to manufacturers of diagnostics and therapies for COVID-19

Coronavirus testing services to expand by 500%

Hyperimmune globulin treatment for COVID-19 planned

WHO chief says Europe is now the epicentre of the COVID-19 pandemic